Free Trial

ENDRA Life Sciences (NDRA) SEC Filings & 10K Form

ENDRA Life Sciences logo
$5.05 -0.05 (-0.90%)
Closing price 01/31/2025 03:58 PM Eastern
Extended Trading
$4.81 -0.24 (-4.83%)
As of 01/31/2025 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ENDRA Life Sciences SEC Filings

DateFilerForm TypeView
11/22/2024
7:42 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
4:14 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 10-Q/A
11/19/2024
4:14 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
7:00 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
4:28 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form DEF 14A
09/06/2024
3:33 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form PRE 14A
09/05/2024
2:28 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group AG (Reporting)
Form 4/A
09/05/2024
1:47 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group AG (Reporting)
Form 3/A
08/29/2024
3:30 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group AG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
11:11 AM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
UBS Group AG (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/28/2024
4:09 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
4:00 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
Jacroux Richard (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/13/2024
8:24 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
7:02 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:16 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
3:16 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form DEFA14A
06/14/2024
7:00 AM
ENDRA Life Sciences Inc. (Subject)
ENDRA Life Sciences (Subject)
ENDRA Life Sciences Inc. (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SC 13G
06/12/2024
4:22 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form PRE 14A
06/06/2024
7:00 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
7:20 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 424B3
06/04/2024
11:15 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form EFFECT
05/20/2024
7:05 AM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:17 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
4:17 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form S-1/A
05/10/2024
4:18 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2024
3:05 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
4:10 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/03/2024
11:15 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form EFFECT
03/28/2024
3:10 PM
ENDRA Life Sciences Inc. (Filer)
ENDRA Life Sciences (Filer)
ENDRA Life Sciences Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
4:00 PM
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
Tokman Alexander Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
DIGIANDOMENICO ANTHONY (Reporting)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:00 PM
Basenese Lou (Reporting)
ENDRA Life Sciences Inc. (Issuer)
ENDRA Life Sciences (Issuer)
ENDRA Life Sciences Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NDRA) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners